Scarica l'app Stockscreener
42.38
2.34%
0.97
Precedente Chiudi:
$41.41
Aprire:
$41.36
Volume 24 ore:
525.87K
Relative Volume:
1.03
Capitalizzazione di mercato:
$2.11B
Reddito:
$499.95M
Utile/perdita netta:
$-36.36M
Rapporto P/E:
-55.04
EPS:
-0.77
Flusso di cassa netto:
$24.22M
1 W Prestazione:
+6.32%
1M Prestazione:
+28.19%
6M Prestazione:
+31.09%
1 anno Prestazione:
+29.25%
Intervallo 1D:
$41.08
$42.44
Intervallo di 1 settimana:
$38.92
$42.44
Portata 52W:
$28.29
$43.11
Atricure Inc Stock (ATRC) Company Profile
Nome
Atricure Inc
Settore
Industria
Telefono
513-755-4100
Indirizzo
7555 INNOVATION WAY, MASON, OH
Confronta ATRC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
42.38 | 2.06B | 499.95M | -36.36M | 24.22M | -0.77 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-04-23 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2021-08-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Reiterato | Needham | Buy |
| 2020-11-06 | Reiterato | Needham | Buy |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-24 | Reiterato | Needham | Buy |
| 2019-08-13 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Iniziato | JP Morgan | Overweight |
| 2018-10-04 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Stifel | Buy |
| 2018-06-18 | Reiterato | Needham | Buy |
| 2018-04-27 | Reiterato | Needham | Buy |
| 2018-01-16 | Reiterato | Needham | Buy |
| 2017-11-02 | Reiterato | Needham | Buy |
| 2017-07-28 | Reiterato | Needham | Buy |
| 2017-05-30 | Ripresa | Piper Jaffray | Overweight |
| 2016-06-30 | Ripresa | JMP Securities | Mkt Outperform |
| 2015-10-28 | Reiterato | Needham | Buy |
| 2015-10-06 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-06 | Reiterato | Needham | Buy |
Mostra tutto
Atricure Inc Borsa (ATRC) Ultime notizie
Loss Report: What valuation multiples suggest for AtriCure Inc stockJuly 2025 Outlook & Fast Entry Momentum Alerts - moha.gov.vn
AtriCure treats first patients with dual PFA/RF system - MedTech Dive
ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform - Finviz
AtriCure reports first patients treated with dual-energy PFA, RF platform - MassDevice
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform - 01net
AtriCure Reports 1st Treatments with Dual Energy RF, PFA System - Medical Product Outsourcing
AtriCure Says First Patients Treated With Dual-Energy Platform - marketscreener.com
AtriCure (ATRC) Introduces Cutting-Edge Dual Energy Platform in Initial Treatments - GuruFocus
AtriCure (Nasdaq: ATRC) Debuts Dual PFA-RF Surgical Ablation System in First Human Use - Stock Titan
AtriCure, Inc.'s (NASDAQ:ATRC) 29% Share Price Surge Not Quite Adding Up - simplywall.st
Russell Investments Group Ltd. Decreases Stake in AtriCure, Inc. $ATRC - MarketBeat
AtriCure Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Are Medical Stocks Lagging AtriCure (ATRC) This Year? - Yahoo Finance
Hood River Capital Management LLC Has $100.31 Million Holdings in AtriCure, Inc. $ATRC - MarketBeat
Will AtriCure Inc. stock deliver strong dividend growthPortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser
Why analysts remain bullish on AtriCure Inc. stock2025 Trading Recap & Consistent Growth Stock Picks - Newser
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares? - AOL.com
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance - MSN
Geode Capital Management LLC Purchases 14,577 Shares of AtriCure, Inc. $ATRC - MarketBeat
How supply chain issues affect AtriCure Inc. stockJuly 2025 Volume & Scalable Portfolio Growth Methods - BỘ NỘI VỤ
Insider Selling: AtriCure (NASDAQ:ATRC) Director Sells 4,967 Shares of Stock - MarketBeat
Atricure Executives Make Significant Stock Sales - TipRanks
Insider Sell: Justin Noznesky Sells 5,166 Shares of AtriCure Inc (ATRC) - GuruFocus
AtriCure Executives Engage in Stock Transactions - TradingView
Atricure Insider Sold Shares Worth $376,578, According to a Recent SEC Filing - MarketScreener
Dir Wehrwein Sells 10,000 ($376.6K) Of AtriCure Inc [ATRC] - TradingView
Officer Noznesky Sells 5,166 ($192.6K) Of AtriCure Inc [ATRC] - TradingView
ATRC Form 4: Director exercises $19.95 options, trims holdings - Stock Titan
[Form 4] AtriCure, Inc. Insider Trading Activity - Stock Titan
Precision Trading with Atricure Inc. (ATRC) Risk Zones - news.stocktradersdaily.com
Officer Noznesky Files To Sell 5,166 Of AtriCure Inc [ATRC] - TradingView
Atricure Director Makes a Significant Stock Sale! - TipRanks
AtriCure director Yuen sells $107k in shares By Investing.com - Investing.com Australia
Wall Street Analysts Believe AtriCure (ATRC) Could Rally 36.3%: Here's is How to Trade - Finviz
Insider Sell: Maggie Yuen Sells 3,000 Shares of AtriCure Inc (AT - GuruFocus
AtriCure director Yuen sells $107k in shares - Investing.com
AtriCure Director Maggie Yuen Sells 3,000 Shares - TradingView
Dir Wehrwein Files To Sell 5,033 Of AtriCure Inc [ATRC] - TradingView
AtriCure, Inc. $ATRC Stake Boosted by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Dir Yuen Files To Sell 3,000 Of AtriCure Inc [ATRC] - TradingView
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Why AtriCure Inc. stock remains on buy lists2025 Growth vs Value & Safe Entry Momentum Stock Tips - newser.com
How AtriCure Inc. stock performs in rate cut cycles2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
How sustainable is AtriCure Inc. stock dividend payoutTrade Performance Summary & Safe Swing Trade Setups - newser.com
Why AtriCure Inc. stock attracts high net worth investorsTrade Entry Report & Risk Managed Investment Strategies - newser.com
AtriCure Inc. stock trendline breakdownJuly 2025 Reactions & Real-Time Stock Movement Alerts - newser.com
Atricure Inc Azioni (ATRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.32%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):